| 2024-03-07 16:13 | CC:HEM | Hemostemix Inc (2) | 0.08 | News Release200 | Hemostemix hires Oak Hill for advisory services |
| 2024-02-06 14:15 | CC:HEM | Hemostemix Inc (2) | | News Release200 | Hemostemix releases clinical results via Biomedical |
| 2024-01-03 20:06 | CC:HEM | Hemostemix Inc (2) | 0.07 | Private Placement250 | Hemostemix 2,669,875-share private placement |
| 2023-12-29 16:15 | CC:HEM | Hemostemix Inc (2) | 0.07 | News Release200 | Hemostemix clarifies Oct. 3 PR on private placement |
| 2023-12-15 17:44 | CC:HEM | Hemostemix Inc (2) | 0.07 | Private Placement - Debenture255 | Hemostemix debentures amended |
| 2023-11-29 18:15 | CC:HEM | Hemostemix Inc (2) | 0.07 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-29 18:13 | CC:HEM | Hemostemix Inc (2) | 0.07 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-10-30 15:19 | CC:HEM | Hemostemix Inc (2) | 0.085 | News Release200 | Hemostemix's ACP-01 study published in Stem Cell |
| 2023-10-23 14:42 | CC:HEM | Hemostemix Inc (2) | 0.10 | News Release200 | Hemostemix amends terms of $2.5-million debenture |
| 2023-10-03 14:12 | CC:HEM | Hemostemix Inc (2) | 0.12 | News Release200 | Hemostemix closes $320,125 private placement |
| 2023-10-02 19:36 | CC:HEM | Hemostemix Inc (2) | 0.12 | Private Placement250 | Hemostemix 3,362,833-unit private placement |
| 2023-09-27 17:15 | CC:HEM | Hemostemix Inc (2) | 0.105 | News Release200 | Hemostemix arranges $325,125 private placement |
| 2023-09-12 17:06 | CC:HEM | Hemostemix Inc (2) | 0.115 | News Release200 | Hemostemix submits NCP-01 study for peer review |
| 2023-08-29 16:14 | CC:HEM | Hemostemix Inc (2) | 0.125 | News Release200 | Hemostemix forms Hemostemix Quebec |
| 2023-08-29 15:47 | CC:HEM | Hemostemix Inc (2) | 0.12 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-08-29 15:44 | CC:HEM | Hemostemix Inc (2) | 0.12 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-08-14 12:00 | CC:HEM | Hemostemix Inc (2) | 0.145 | News Release200 | Hemostemix wins arbitration against Burchardt |
| 2023-08-08 15:14 | CC:HEM | Hemostemix Inc (2) | 0.14 | News Release200 | Hemostemix submits cardiomyopathy study |
| 2023-06-28 16:09 | CC:HEM | Hemostemix Inc (2) | 0.12 | News Release200 | Hemostemix closes $403,539 tranche of private placement |
| 2023-06-21 17:13 | CC:HEM | Hemostemix Inc (2) | 0.12 | News Release200 | Hemostemix outlines use of proceeds from financing |
| 2023-06-01 21:03 | CC:HEM | Hemostemix Inc (2) | 0.13 | News Release200 | Hemostemix arranges 10-million-unit private placement |
| 2023-05-29 17:50 | CC:HEM | Hemostemix Inc (2) | 0.13 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-05-29 17:50 | CC:HEM | Hemostemix Inc (2) | 0.13 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-05-02 11:02 | CC:HEM | Hemostemix Inc (2) | 0.16 | News Release200 | Hemostemix hires McNorgan for NCP-01 licensing |
| 2023-05-02 10:51 | CC:HEM | Hemostemix Inc (2) | 0.16 | Resume Trading385 | Hemostemix to resume at 8:15 a.m. PT |
| 2023-05-02 09:20 | CC:HEM | Hemostemix Inc (2) | 0.16 | Halt Trading170 | Hemostemix halted at the open |
| 2023-05-01 17:02 | CC:HEM | Hemostemix Inc (2) | 0.16 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-05-01 16:58 | CC:HEM | Hemostemix Inc (2) | 0.16 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |